FDA Drug Shortage Database
Methylphenidate (Ritalin) shortage
The FDA Drug Shortage Database lists 15 of 38 methylphenidate presentations as limited or unavailable (updated October 1, 2026); the first entry was posted on July 26, 2023. 23 more presentations are on the list as available.
- Generic listed
- In shortage
- Boxed warning
- DEA Schedule II
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 10mg | 0 | 1 | 0 |
| 15mg | 0 | 1 | 0 |
| 18mg tablet | 3 | 4 | 0 |
| 20mg | 0 | 1 | 0 |
| 27mg tablet | 3 | 4 | 0 |
| 30mg | 0 | 1 | 0 |
| 36mg tablet | 4 | 3 | 0 |
| 45mg tablet | 1 | 1 | 0 |
| 54mg tablet | 2 | 5 | 0 |
| 63mg tablet | 1 | 1 | 0 |
| 72mg tablet | 1 | 1 | 0 |
Which presentations are listed?
Limited or unavailable now (15)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10) | Trigen Laboratories, LLC | Current posted July 26, 2023, updated October 1, 2026 | Limited Availability; Demand increase for the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 26, 2023, updated September 18, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 26, 2023, updated October 1, 2026 | Limited Availability; Other |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10) | Trigen Laboratories, LLC | Current posted July 26, 2023, updated October 1, 2026 | Limited Availability; Demand increase for the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 26, 2023, updated September 18, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37) | Lannett Company, Inc. | Current posted July 26, 2023, updated October 1, 2026 | Unavailable; Other |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10) | Trigen Laboratories, LLC | Current posted July 26, 2023, updated October 1, 2026 | Limited Availability; Demand increase for the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 26, 2023, updated September 18, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 26, 2023, updated October 1, 2026 | Limited Availability; Other |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37) | Lannett Company, Inc. | Current posted July 26, 2023, updated October 1, 2026 | Unavailable; Other |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30) | Trigen Laboratories, LLC | Current posted July 26, 2023, updated October 1, 2026 | Limited Availability; Demand increase for the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10) | Trigen Laboratories, LLC | Current posted July 26, 2023, updated October 1, 2026 | Limited Availability; Demand increase for the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 26, 2023, updated September 18, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30) | Trigen Laboratories, LLC | Current posted July 26, 2023, updated October 1, 2026 | Limited Availability; Demand increase for the drug |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30) | Trigen Laboratories, LLC | Current posted July 26, 2023, updated October 1, 2026 | Limited Availability; Demand increase for the drug |
Listed now, available (23)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01) | Janssen Pharmaceuticals | Current posted July 26, 2023, updated September 17, 2026 | Available |
| Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01) | Janssen Pharmaceuticals | Current posted July 26, 2023, updated September 17, 2026 | Available |
| Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01) | Janssen Pharmaceuticals | Current posted July 26, 2023, updated September 17, 2026 | Available |
| Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01) | Janssen Pharmaceuticals | Current posted July 26, 2023, updated September 17, 2026 | Available |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37) | Lannett Company, Inc. | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37) | Lannett Company, Inc. | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65) | Noven Pharmaceuticals, Inc. | Current posted February 28, 2025, updated September 2, 2026 | Available |
| Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65) | Noven Pharmaceuticals, Inc. | Current posted February 28, 2025, updated September 2, 2026 | Available |
| Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65) | Noven Pharmaceuticals, Inc. | Current posted February 28, 2025, updated September 2, 2026 | Available |
| Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65) | Noven Pharmaceuticals, Inc. | Current posted February 28, 2025, updated September 2, 2026 | Available |
| Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
| Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30) | Vertical Pharmaceuticals, LLC | Current posted July 26, 2023, updated October 1, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Amphetamine and dextroamphetamine | ADHD | In shortage | 25 labelers | $0.233 per tablet 10 mg tablet |
| Lisdexamfetamine | ADHD | In shortage | 19 labelers | $2.44 per capsule 20 mg capsule |
| Dexmethylphenidate | ADHD | No current entry | 13 labelers | $1.45 per capsule 10 mg capsule |
| Amphetamine | ADHD | No current entry | 13 labelers | $0.449 per tablet 10 mg tablet |
| Dextroamphetamine | ADHD | No current entry | 14 labelers | $0.373 per tablet 10 mg tablet |
| Dexmethylphenidate and serdexmethylphenidate | ADHD | No current entry | none listed | $14.40 per capsule 26.1 mg-5.2 mg capsule |
| Methamphetamine | ADHD | No current entry | 3 labelers | $5.10 per tablet 5 mg tablet |
| Atomoxetine | ADHD | No current entry | 20 labelers | $0.442 per capsule 40 mg capsule |
| Guanfacine | ADHD | A presentation being discontinued | 36 labelers | $0.147 per tablet 1 mg tablet |
| Viloxazine | ADHD | No current entry | none listed | $12.74 per capsule 200 mg capsule |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage